The White House considers healthcare reform to be vital to a U.S. economic recovery and wants the legislation approved by the end of the year. Read Summary >
An expert panel that advises the U.S. Food and Drug Administration has voted unanimously to recommend a new drug called Saphris for the treatment of bipolar I disorder and schizophrenia. Read Summary >
The rate at which Americans are spending money on mental health care is rising faster than their spending on any other kind of health care, a new government report has found. Read Summary >
Invega Sustenna is a once-monthly injected medication designed to help prevent symptom relapses in schizophrenia patients who fail to take a more frequent dose of the medicine. Read Summary >
Experts are concerned that posting images and interpretations from the Rorscach test could affect the accuracy of its use with patients. Read Summary >
The House Energy and Commerce Committee has approved a sweeping bill designed to overhaul the U.S. healthcare system, clearing the way for a vote by the full House in the fall. Read Summary >
Bifeprunox did not show enough effect in a recent trial to warrant further study of the drug as a treatment for acute schizophrenia symptoms, its makers say. Read Summary >
